Nano X Imaging Ltd (NNOX) - Net Assets
Based on the latest financial reports, Nano X Imaging Ltd (NNOX) has net assets worth $156.71 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($176.09 Million) and total liabilities ($19.38 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Nano X Imaging Ltd to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $156.71 Million |
| % of Total Assets | 89.0% |
| Annual Growth Rate | N/A |
| 5-Year Change | -18.04% |
| 10-Year Change | N/A |
| Growth Volatility | 18.57 |
Nano X Imaging Ltd - Net Assets Trend (2018–2024)
This chart illustrates how Nano X Imaging Ltd's net assets have evolved over time, based on quarterly financial data. Also explore NNOX asset base for the complete picture of this company's asset base.
Annual Net Assets for Nano X Imaging Ltd (2018–2024)
The table below shows the annual net assets of Nano X Imaging Ltd from 2018 to 2024. For live valuation and market cap data, see how much is Nano X Imaging Ltd worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $189.12 Million | -3.27% |
| 2023-12-31 | $195.51 Million | -12.98% |
| 2022-12-31 | $224.68 Million | -23.09% |
| 2021-12-31 | $292.15 Million | +26.61% |
| 2020-12-31 | $230.75 Million | +2728.69% |
| 2019-12-31 | $-8.78 Million | -37.50% |
| 2018-12-31 | $-6.38 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nano X Imaging Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 35571100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $181.00K | 0.10% |
| Other Comprehensive Income | $-1.00K | 0.00% |
| Other Components | $562.69 Million | 297.53% |
| Total Equity | $189.12 Million | 100.00% |
Nano X Imaging Ltd Competitors by Market Cap
The table below lists competitors of Nano X Imaging Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kbi Metal Co. Ltd
KQ:024840
|
$120.41 Million |
|
M.C.S. Steel Public Company Limited
BK:MCS
|
$120.43 Million |
|
Supergas Energy Ltd
TA:SPGE
|
$120.50 Million |
|
Lumi Gruppen AS
OL:LUMI
|
$120.51 Million |
|
SHANGHAI FUDAN H YC-,10
F:FDY
|
$120.04 Million |
|
Globe Union Industrial Corp
TW:9934
|
$120.04 Million |
|
Impact Develop
RO:IMP
|
$120.01 Million |
|
Servotronics Inc
NYSE MKT:SVT
|
$120.00 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nano X Imaging Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 195,514,000 to 189,119,000, a change of -6,395,000 (-3.3%).
- Net loss of 53,516,000 reduced equity.
- New share issuances of 37,834,000 increased equity.
- Other comprehensive income increased equity by 304,000.
- Other factors increased equity by 8,983,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-53.52 Million | -28.3% |
| Share Issuances | $37.83 Million | +20.01% |
| Other Comprehensive Income | $304.00K | +0.16% |
| Other Changes | $8.98 Million | +4.75% |
| Total Change | $- | -3.27% |
Book Value vs Market Value Analysis
This analysis compares Nano X Imaging Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.54x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $-0.19 | $1.73 | x |
| 2019-12-31 | $-0.19 | $1.73 | x |
| 2020-12-31 | $6.47 | $1.73 | x |
| 2021-12-31 | $6.06 | $1.73 | x |
| 2022-12-31 | $4.30 | $1.73 | x |
| 2023-12-31 | $3.47 | $1.73 | x |
| 2024-12-31 | $3.23 | $1.73 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nano X Imaging Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -28.30%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -474.31%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 1.11x
- Recent ROE (-28.30%) is below the historical average (-20.89%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.27 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-21.68 Million |
| 2020 | -18.85% | 0.00% | 0.00x | 1.02x | $-66.57 Million |
| 2021 | -21.15% | -4739.11% | 0.00x | 1.24x | $-91.01 Million |
| 2022 | -46.84% | -1226.89% | 0.03x | 1.13x | $-127.71 Million |
| 2023 | -31.09% | -613.59% | 0.05x | 1.12x | $-80.33 Million |
| 2024 | -28.30% | -474.31% | 0.05x | 1.11x | $-72.43 Million |
Industry Comparison
This section compares Nano X Imaging Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,432,799,891
- Average return on equity (ROE) among peers: -74.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nano X Imaging Ltd (NNOX) | $156.71 Million | 0.00% | 0.12x | $120.39 Million |
| Abbott Laboratories (ABT) | $24.16 Billion | 9.46% | 0.81x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-13.54K | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $2.15 Million | -112.84% | 0.45x | $16.04 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.60 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $89.39 Million | 8.74% | 0.25x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $21.15 Million | 2.82% | 0.30x | $125.55 Million |
About Nano X Imaging Ltd
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source… Read more